Effects of treatment with etanercept on fatigue, sleepiness, well being, sleep quality and selected immune parameters in patients with rheumatoid arthritis.

Trial Profile

Effects of treatment with etanercept on fatigue, sleepiness, well being, sleep quality and selected immune parameters in patients with rheumatoid arthritis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Sep 2016

At a glance

  • Drugs Etanercept (Primary) ; Methotrexate (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms Schlafprojekt
  • Most Recent Events

    • 12 Sep 2016 Status changed from active, no longer recruiting to completed.
    • 22 Jun 2016 Results published in the Clinical and Experimental Rheumatology
    • 22 Jun 2016 Status changed from recruiting to active, no longer recruiting, as per the results published in the Clinical and Experimental Rheumatology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top